$0.51
+0.02 (+4.62%)
DEFT News30 articles
Robinhood Rallies 2.9% as Bernstein's $160 Target Defies 54.5x P/E
Robinhood rose 2.9% to $123.30, extending a two-day gain of 12.3%. Bernstein's $160 target implies 29.8% upside, but the stock trades at 54.5x trailing earnings.
Canada's Q1 Deficit Narrows Sharply as Revenue Surges 9.8%
Canada's federal deficit narrowed to C$370M in Q1 as revenue surged 9.8%, but debt charges climbed 6.1%, keeping bond markets cautious.
PGA Tour Finalizes 2028 Two-Tier Structure, 90 Cards Define New Era
PGA Tour finalizes 2028 two-tier system: 90 cards retained, 20 promotions. New structure aims to boost media value, with $3B investment from Strategic Sports Group.
Indonesia's New Finance Minister Faces 2.4% Deficit Test
Indonesia appoints Suahasil Nazara as finance minister. Markets now test his commitment to the 2.4% GDP deficit target amid currency weakness.
DeFi Development Expands CHAD Preferred ATM to $300M for Solana Treasury
DeFi Development Corp. has launched an at-the-market program for 30 million CHAD preferred shares, potentially raising $300M to fund Solana (SOL) acquisitions and strategic initiatives.
ASX 200 Slips 1.2% as Miners Weigh; ASX Ltd Defies Decline
The ASX 200 dropped 1.21% to 8,712.9, driven by heavy mining losses, while ASX Ltd fell only 0.9% as trading volumes surged on volatility.
BVB Shares Face Monday Test After Supercup Loss and Annual Deficit
Borussia Dortmund shares face Monday trading after a Supercup loss and €21.7M annual deficit. Revenue fell 12.5%, but sponsorship income rose 4.5%.
Boeing's $5.6B Slide Reflects Persistent Trust Deficit
Boeing's stock dropped 3.2%, erasing $5.6B in market cap, as a Netflix documentary reignited safety concerns and sector-wide declines pressured shares.
Cemex Poised for $41M FX Boost as Peso Strength Defies Forecasts
With USD/MXN near 17, Cemex could see a $41 million translation benefit on Mexico EBITDA, as the peso trades well below its H2 planning range.
Social Security COLA Plan Could Halve Deficit but Offers Only Two-Year Extension
A fixed-rate COLA proposal could halve Social Security's 75-year deficit but extends solvency by only two years. AARP opposes the PROMISE Act's fast-track process.
Nuvve Holdings Plunges 46% as Nasdaq Suspension Looms Over Capital Deficit
Nuvve Holding Corp. (NASDAQ:NVVE) shares plummeted 46% on Thursday after Nasdaq announced a suspension due to a capital shortfall, with trading expected to shift to OTC markets.
Oracle Stock Rebounds Amid $24 Billion Cash Flow Deficit
Oracle shares recovered 1.77% on Friday to $126.41, but ended the week down 10.1% amid a $23.7 billion free cash flow deficit and S&P downgrade.
Nvidia Defies Chip Rout as Analysts Lift Earnings Forecasts
Nvidia dropped 3.9% last week but beat the chip index by 6.1 percentage points. Analysts boosted FY2027 and FY2028 EPS estimates, pointing to improving earnings per dollar.
Microsoft Defies Nasdaq Slump as AI Strategy Shields Stock
Microsoft shares rose 1.8% on Thursday, extending gains to 4.6% over two sessions and adding $132 billion in market value, as the stock outperformed a falling Nasdaq.
Bending Spoons' Extreme Hiring Selectivity and Founder Control Define Post-IPO Landscape
Bending Spoons hired just 286 of 800,000 applicants in 2025, while its founders control 82.71% of votes post-IPO. Shares have dropped 18.7% from the debut close.
Coeur Mining Rallies on Index Inclusion, Defies Silver Slump
Coeur Mining (CDE) rose 1.94% Monday, beating gold and silver ETFs, as its recent addition to the S&P MidCap 400 drew index-driven buying despite a drop in metals prices.
Palo Alto Networks Surges $8.7B as Cybersecurity Strength Defies Tech Selloff
Palo Alto Networks rose 3.7% to $304.20, adding $8.7 billion in market cap, as its IBM partnership and solid earnings helped it buck a 4.6% weekly Nasdaq drop.
Definium Shares Surge on LSD-Based Depression Drug Trial Success
DFTX shares soared 64.2% premarket after Definium's Phase 3 Emerge trial showed DT120 achieved an 8.1-point placebo-adjusted benefit in major depressive disorder.
BitGo Opens DeFi Vaults to Institutions Amid Stablecoin Arms Race
BitGo Bank & Trust launches DeFi gateway for institutions via Narval, granting access to Aave, Spark, and Tesseract while maintaining qualified custody and compliance controls.
Altria Defies Market Selloff Amid FDA Policy Scrutiny
Altria surged 2.25% to $72.19 on Friday, defying a broad market selloff, as investors assessed Senate scrutiny of FDA vape policy and a June 15 dividend cutoff.
P&G Defies Market Slide: Can the Rally Hold?
P&G surged 4.09% to $146.54 as investors rotated into defensive staples, but shares remain below their 52-week high amid margin headwinds.
Mirion Defies Market Downturn, Nuclear Focus Drives Gains
Mirion shares climbed 1.1% on strong volume as nuclear safety catalysts offset a broad market selloff and mixed earnings signals.
Senate Panel Advances Crypto Bill, DeFi Pushback and Stablecoin Issues Remain
The Digital Asset Market Clarity Act passed the Senate Banking Committee 15-9 but faces new opposition from DeFi developers and key Democrats over securities amendments and stablecoin provisions.
3M Defies Market Slide, Dividend and Earnings in Focus
3M shares rose 0.76% to $146.22, outperforming a broad market drop. The company declared a 78-cent quarterly dividend and reported Q1 adjusted EPS of $2.14, up 14%.
Coca-Cola Defies Market Slide, Eyes New Hurdles
Coca-Cola shares closed the week up 3.1% at $80.82, near a 52-week high, as the S&P 500 and Dow fell. The company faces headwinds from rising packaging costs and cautious consumers.
SolarEdge Surges Nearly 50% in a Week; Monday Session Could Define Trend
SolarEdge shares surged nearly 50% in a week, closing Friday at $61.76. The rally was fueled by Q1 revenue, strong Q2 guidance, and tax-credit deadline demand. Monday's session will test the breakout.
Palantir Defies AI Selloff, Stays Steady as Nasdaq Slips
Palantir closed Friday at $133.99, up 0.2%, showing relative strength despite a weekly loss of 2.8% and a broader tech selloff.
Markets Navigate Geopolitics and Earnings as Tech Defies Broader Weakness
Indian markets declined sharply as HCL Technologies led an IT sector sell-off, while U.S. technology stocks showed resilience despite geopolitical tensions. Key earnings reports from Nasdaq and East West Bancorp are in focus.
Hoskinson: XRP Holders Lack Claim to Ripple's Corporate Gains as Cardano Advances DeFi Integration
Charles Hoskinson clarifies that XRP ownership does not grant rights to Ripple's corporate profits, even as Cardano continues developing its plan to incorporate XRP into its decentralized finance infrastructure.
Definium's Psychedelic Drug DT120 Gains Analyst Backing Ahead of Key 2026 Data
Definium Therapeutics advanced after Stifel and Piper Sandler issued Buy ratings, spotlighting its LSD-based drug DT120 in late-stage trials for anxiety and depression. The company will host an investor day on April 22 to discuss upcoming Phase 3 data expected through 2026.